{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T18:46:37Z","timestamp":1775155597112,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T00:00:00Z","timestamp":1673568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T00:00:00Z","timestamp":1673568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-022-04771-7","type":"journal-article","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T06:07:29Z","timestamp":1673590049000},"page":"1299-1308","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The use of calgranulin-C (S100A12) and fecal zonulin as possible non-invasive markers in children with inflammatory bowel disease: a clinical study"],"prefix":"10.1007","volume":"182","author":[{"given":"Sabrina","family":"Cenni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianna","family":"Casertano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Trani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Pacella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annamaria","family":"Staiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erasmo","family":"Miele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Strisciuglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,13]]},"reference":[{"issue":"11","key":"4771_CR1","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1001\/jamapediatrics.2015.1982","volume":"169","author":"MJ Rosen","year":"2015","unstructured":"Rosen MJ, Dhawan A, Saeed SA (2015) Inflammatory bowel disease in children and adolescents. JAMA Pediatr 169(11):1053\u20131060","journal-title":"JAMA Pediatr"},{"key":"4771_CR2","doi-asserted-by":"publisher","unstructured":"Langhorst J, Elsenbruch S, Mueller T, Rueffer A, Spahn G, Michalsen , Dobos GJ (2005) Comparison of 4 neutrophil-derived proteins in feces as indicators of disease activity in ulcerative colitis. Inflammatory Bowel Dis 11(12):1085\u20131091. https:\/\/doi.org\/10.1097\/01.MIB.0000187980.08686.18","DOI":"10.1097\/01.MIB.0000187980.08686.18"},{"key":"4771_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cca.2007.02.025","volume":"381","author":"I Angriman","year":"2007","unstructured":"Angriman I, Scarpa M, D\u2019Inc\u00e0 R, Basso D, Ruffolo C, Polese L, Sturniolo G, D\u2019amico D, Plebani M (2007) Enzymes in feces: useful markers of chronic inflammatory bowel disease. Clin Chim Acta 381:63\u201368","journal-title":"Clin Chim Acta"},{"issue":"41","key":"4771_CR4","doi-asserted-by":"publisher","first-page":"7387","DOI":"10.3748\/wjg.v23.i41.7387","volume":"23","author":"A Kostas","year":"2017","unstructured":"Kostas A, Siakavellas SI, Kosmidis C, Takou A, Nikou J, Maropoulos G, Vlachogiannakos J, Papatheodoridis GV, Papaconstantinou I, Bamias G (2017) Faecal calprotectin measurement is a marker of short term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease. World J Gastroenterol 23(41):7387\u20137396","journal-title":"World J Gastroenterol"},{"key":"4771_CR5","doi-asserted-by":"crossref","unstructured":"Johne B, Kronborg O, T\u00f8n HI, Kristinsson J, Fuglerud P (2001) A new faecal calprotectin test for colorectal neoplasia. Clinical results and comparison with previous method. Scand J Gastroenterol 36:291\u2013296","DOI":"10.1080\/003655201750074618"},{"key":"4771_CR6","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/1751-2980.12012","volume":"14","author":"F van de Logt","year":"2013","unstructured":"van de Logt F, Day AS (2013) S100A12: a noninvasive marker of inflammation in inflammatory bowel disease. J Dig Dis 14:62\u201367","journal-title":"J Dig Dis"},{"key":"4771_CR7","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1136\/gut.2010.211755","volume":"59","author":"D Turner","year":"2010","unstructured":"Turner D, Leach ST, Mack D, Uusoue K, McLernon R, Hyams J, Leleiko N, Walters TD, Crandall W, Markowitz J, Otley AR, Griffiths AM, Day AS (2010) Faecal calprotectin, lactoferrin, M2- pyruvate kinase and S100A12 in severe ulcerative colitis: a prospective multicenter comparison of predicting outcomes and monitoring response. Gut 59:1207\u20131212","journal-title":"Gut"},{"key":"4771_CR8","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1136\/gut.52.6.847","volume":"52","author":"D Foell","year":"2003","unstructured":"Foell D, Kucharzik T, Kraft M, Vogl T, Sorg C, Domschke W, Roth J (2003) Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease. Gut 52:847\u2013853","journal-title":"Gut"},{"key":"4771_CR9","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1080\/00365520701416709","volume":"42","author":"ST Leach","year":"2007","unstructured":"Leach ST, Yang Z, Messina I, Song C, Geczy CL, Cunningham AM, Day AS (2007) Serum and mucosal S100 proteins, calprotectin (S100A8\/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease. Scand J Gastroenterol 42:1321\u20131331","journal-title":"Scand J Gastroenterol"},{"issue":"12","key":"4771_CR10","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1136\/gut.2006.113431","volume":"56","author":"T Kaiser","year":"2007","unstructured":"Kaiser T, Langhorst J, Wittkowski H, Becker K, Friedrich AW, Rueffer A, Dobos GJ, Roth J, Foell D (2007) Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome. Gut 56(12):1706\u20131713","journal-title":"Gut"},{"key":"4771_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.plabm.2017.09.001","volume":"9","author":"K Mal\u00ed\u010dkov\u00e1a","year":"2017","unstructured":"Mal\u00ed\u010dkov\u00e1a K, Francov\u00e1a I, Luk\u00e1\u0161 M, Kol\u00e1\u0159 M, Kr\u00e1l\u00edkov\u00e1 E, Bortl\u00edk M, \u010euricov\u00e1 D, \u0160t\u011bp\u00e1nkov\u00e1 L, Zvolsk\u00e1 K, P\u00e1nkov\u00e1 A, Zimaa T (2017) Faecal zonulin is elevated in Crohn\u2019s disease and in cigarette smokers. Pract Lab Med 9:39\u201344","journal-title":"Pract Lab Med"},{"key":"4771_CR12","doi-asserted-by":"crossref","unstructured":"Levine A, Koletzko S, Turner D et al (2014) European Society of Pediatric Gastroenterology, Hepatology, and Nutrition. ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. J Pediatr Gastroenterol Nutr 58:795\u2013806","DOI":"10.1097\/MPG.0000000000000239"},{"issue":"6","key":"4771_CR13","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1002\/ibd.21493","volume":"17","author":"A Levine","year":"2011","unstructured":"Levine A, Griffiths A, Markowitz J et al (2011) Pediatric modification of the montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis 17(6):1314\u20131321","journal-title":"Inflamm Bowel Dis"},{"key":"4771_CR14","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1097\/00005176-199105000-00005","volume":"12","author":"JS Hyams","year":"1991","unstructured":"Hyams JS, Ferry GD, Mandel FS et al (1991) Development and validation of a pediatric Crohn\u2019s disease activity index. J Pediatr Gastroenterol Nutr 12:439\u2013447","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"4771_CR15","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1053\/j.gastro.2007.05.029","volume":"133","author":"D Turner","year":"2007","unstructured":"Turner D, Otley AR, Mack D et al (2007) Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology 133:423\u2013432","journal-title":"Gastroenterology"},{"issue":"5","key":"4771_CR16","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1053\/j.gastro.2013.07.024","volume":"145","author":"SPL Travis","year":"2013","unstructured":"Travis SPL, Schnell D, Krzeski P et al (2013) Reliability and initial validation of the ulcerative colitis endoscopic index of severity. Gastroenterology 145(5):987\u2013995","journal-title":"Gastroenterology"},{"issue":"4","key":"4771_CR17","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0016-5107(04)01878-4","volume":"60","author":"M Daperno","year":"2004","unstructured":"Daperno M, D\u2019Haens G, Van Assche G et al (2004) Development and validation of a new, simplified endoscopic activity score for Crohn\u2019s disease: the SES-CD. Gastrointest Endosc 60(4):505\u2013512","journal-title":"Gastrointest Endosc"},{"issue":"2","key":"4771_CR18","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/01.MIB.0000437735.11953.68","volume":"20","author":"A Levine","year":"2014","unstructured":"Levine A, Turner D, Pfeffer Gik T et al (2014) Comparison of outcomes parameters for induction of remission in New Onset Pediatric Crohn\u2019s Disease: evaluation of the Porto IBD Group \u2018\u201cGrowth Relapse and Outcomes with Therapy\u201d\u2019 (GROWTH CD) Study. Inflamm Bowel Dis 20(2):278\u2013285","journal-title":"Inflamm Bowel Dis"},{"issue":"10","key":"4771_CR19","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1001\/jamapediatrics.2017.1736","volume":"171","author":"GA Holtman","year":"2017","unstructured":"Holtman GA, Lisman-van Leeuwen Y, Day AS et al (2017) Use of laboratory markers in addition to symptoms for diagnosis of inflammatory bowel disease in children: a meta-analysis of individual patient data. JAMA Pediatr 171(10):984\u2013991","journal-title":"JAMA Pediatr"},{"key":"4771_CR20","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s13312-019-1509-3","volume":"56","author":"M Sridhar","year":"2019","unstructured":"Sridhar M, Kesavelu D (2019) Faecal calprotectin as a screening marker for inflammatory bowel disease. Indian Pediatr 56:249\u2013250","journal-title":"Indian Pediatr"},{"key":"4771_CR21","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/ajg.2013.131","volume":"109","author":"P Henderson","year":"2014","unstructured":"Henderson P, Anderson NH, Wilson DC (2014) The diagnostic accuracy of faecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease: a systematic review and meta-analysis. Am J Gastroenterol 109:637\u2013645","journal-title":"Am J Gastroenterol"},{"key":"4771_CR22","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3109\/00365521.2014.987809","volume":"50","author":"T Sipponen","year":"2015","unstructured":"Sipponen T, Kolho K (2015) Faecal calprotectin in diagnosis and clinical assessment of inflammatory bowel disease. Scand J Gastroenterol 50:74\u201380","journal-title":"Scand J Gastroenterol"},{"issue":"6","key":"4771_CR23","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1097\/MIB.0000000000001082","volume":"23","author":"A Heida","year":"2017","unstructured":"Heida A, Park K, van Rheenen PF (2017) Clinical utility of faecal calprotectin monitoring in asymptomatic patients with inflammatory bowel disease: a systematic review and practical guide. Inflamm Bowel Dis 23(6):894\u2013902","journal-title":"Inflamm Bowel Dis"},{"key":"4771_CR24","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s10620-012-2347-5","volume":"58","author":"ID Kostakis","year":"2013","unstructured":"Kostakis ID, Cholidou KG, Vaiopoulos AG, Vlachos IS, Perrea D, Vaos G (2013) Faecal calprotectin in pediatric inflammatory bowel disease: a systematic review. Dig Dis Sci 58:309\u2013319","journal-title":"Dig Dis Sci"},{"key":"4771_CR25","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1097\/00054725-200606000-00013","volume":"12","author":"MR Konikoff","year":"2006","unstructured":"Konikoff MR, Denson LA (2006) Role of faecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease. Inflamm Bowel Dis 12:524\u2013534","journal-title":"Inflamm Bowel Dis"},{"issue":"40","key":"4771_CR26","doi-asserted-by":"publisher","first-page":"11469","DOI":"10.3748\/wjg.v21.i40.11469","volume":"21","author":"GJAM Boon","year":"2015","unstructured":"Boon GJAM, Day AS, Mulder CJ, Gearry RB (2015) Are faecal markers good indicators of mucosal healing in inflammatory bowel disease? World J Gastroenterol 21(40):11469\u201311480","journal-title":"World J Gastroenterol"},{"key":"4771_CR27","doi-asserted-by":"crossref","unstructured":"Bunn SK, Bisset W, Campbell Main MJ, Sim Gray E, Olson S, Elaine Golden B (2001) Faecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease. J Pediatr Gastroenterol Nutr 33:14Y22","DOI":"10.1097\/00005176-200107000-00003"},{"issue":"4","key":"4771_CR28","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1097\/MPG.0000000000003046","volume":"72","author":"CR Koninckx","year":"2021","unstructured":"Koninckx CR, Donat E, Benninga MA et al (2021) The use of faecal calprotectin testing in paediatric disorders: a position paper of the European Society for Paediatric Gastroenterology and Nutrition Gastroenterology Committee. J Pediatr Gastroenterol Nutr 72(4):617\u2013640","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"Suppl","key":"4771_CR29","first-page":"273","volume":"16","author":"MK Fagerhol","year":"1980","unstructured":"Fagerhol MK, Dale I, Andersson T (1980) A radioimmunoassay for a granulocyte protein as a marker in studies on the turnover of such cells. Bulletin Europeen de Physiopathologie Respiratoire 16(Suppl):273\u2013282","journal-title":"Bulletin Europeen de Physiopathologie Respiratoire"},{"key":"4771_CR30","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.3109\/00365529309098312","volume":"28","author":"AG R\u00f8seth","year":"1993","unstructured":"R\u00f8seth AG, Kristinsson J, Fagerhol MK, Schj\u00f8nsby H, Aadland E, Nygaard K, Roald B (1993) Faecal calprotectin: a novel test for the diagnosis of colorectal cancer? Scand J Gastroenterol 28:1073\u20131076","journal-title":"Scand J Gastroenterol"},{"key":"4771_CR31","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1136\/gut.45.3.362","volume":"45","author":"J Tibble","year":"1999","unstructured":"Tibble J, Sigthorsson G, Foster R, Scott D, Fagerhol M, Roseth A, Bjarnason I (1999) High prevalence of NSAID enteropathy as shown by a simple faecal test. Gut 45:362\u2013366","journal-title":"Gut"},{"issue":"Pt 2","key":"4771_CR32","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1042\/bj3090395","volume":"309","author":"F Guignard","year":"1995","unstructured":"Guignard F, Mauel J, Markert M (1995) Identification and characterization of a novel human neutrophil protein related to the S100 family. Biochem J 309(Pt 2):395\u2013401","journal-title":"Biochem J"},{"key":"4771_CR33","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/MIB.0000000000000273","volume":"21","author":"G Boschetti","year":"2015","unstructured":"Boschetti G, Garnerro P, Moussata D et al (2015) Accuracies of serum and faecal S100 proteins (calprotectin and calgranulin C) to predict the response to TNF antagonists in patients with Crohn\u2019s disease. Inflamm Bowel Dis 21:331\u2013336","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"4771_CR34","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/ibd.20336","volume":"14","author":"MA Sidler","year":"2008","unstructured":"Sidler MA, Leach ST, Day AS (2008) Faecal S100A12 and faecal calprotectin as noninvasive markers for inflammatory bowel disease in children. Inflamm Bowel Dis 14(3):359\u2013366","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"4771_CR35","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1136\/archdischild-2017-314081","volume":"103","author":"A Heida","year":"2018","unstructured":"Heida A, Van de Vijver E, van Ravenzwaaij D et al (2018) Predicting inflammatory bowel disease in children with abdominal pain and diarrhoea: calgranulin-C versus calprotectin stool tests. Arch Dis Child 103(6):565\u2013571","journal-title":"Arch Dis Child"},{"key":"4771_CR36","first-page":"2683","volume":"96","author":"E Husebye","year":"2001","unstructured":"Husebye E, T\u00f8n H, Berit J (2001) Biological variability of faecal calprotectin in patients referred for colonoscopy without colonic inflammation or neoplasm. Am J Gastroenterol 96:2683","journal-title":"Am J Gastroenterol"},{"key":"4771_CR37","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/ajg.2015.120","volume":"110","author":"MH Mosli","year":"2015","unstructured":"Mosli MH, Zou G, Garg SK et al (2015) C-reactive protein, faecal calprotectin, and stool lactoferrin for detection of endoscopic activity in symptomatic inflammatory bowel disease patients: a systematic review and meta-analysis. Am J Gastroenterol 110:802\u2013819","journal-title":"Am J Gastroenterol"},{"key":"4771_CR38","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.dld.2008.01.017","volume":"40","author":"R Berni Canani","year":"2008","unstructured":"Berni Canani R, Terrin G, Rapacciuolo L et al (2008) Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease. Dig Liver Dis 40:547\u2013553","journal-title":"Dig Liver Dis"},{"issue":"7","key":"4771_CR39","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1097\/01.ibd.0000227626.72271.91","volume":"12","author":"NSH de Jong","year":"2006","unstructured":"de Jong NSH, Leach ST, Day AS (2006) Faecal S100A12: a novel noninvasive marker in children with Crohn\u2019s disease. Inflamm Bowel Dis 12(7):566\u2013572","journal-title":"Inflamm Bowel Dis"},{"key":"4771_CR40","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1136\/gut.27.1.92","volume":"27","author":"P Gomes","year":"1986","unstructured":"Gomes P, du Boulay C, Smith CL, Holdstock G (1986) Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease. Gut 27:92\u201395","journal-title":"Gut"},{"key":"4771_CR41","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1159\/000200755","volume":"50","author":"W Fischbach","year":"1991","unstructured":"Fischbach W, Becker W (1991) Clinical relevance of activity parameters in Crohn\u2019s disease estimated by the faecal excretion of 111In-labeled granulocytes. Digestion 50:149\u2013152","journal-title":"Digestion"},{"key":"4771_CR42","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1053\/j.gastro.2008.06.081","volume":"135","author":"J Van Limbergen","year":"2008","unstructured":"Van Limbergen J, Russell RK, Drummond HE et al (2008) Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology 135:1114\u20131122","journal-title":"Gastroenterology"},{"key":"4771_CR43","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/ibd.21349","volume":"17","author":"EI Benchimol","year":"2011","unstructured":"Benchimol EI, Fortinsky KJ, Gozdyra P, Van den Heuvel M, Van Limbergen J, Griffiths AM (2011) Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm Bowel Dis 17:423\u2013439","journal-title":"Inflamm Bowel Dis"},{"issue":"9214","key":"4771_CR44","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1016\/S0140-6736(00)02169-3","volume":"355","author":"A Fasano","year":"2000","unstructured":"Fasano A, Not T, Wang W et al (2000) Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet 355(9214):1518\u20131519","journal-title":"Lancet"},{"key":"4771_CR45","doi-asserted-by":"crossref","unstructured":"D. Zhang, L. Zhang, Y. Zheng, Yue F, Russell RD, Zeng Y (2014) Circulating zonulin levels in newly diagnosed Chinese type 2 diabetes patients. Diab Res Clin Pract 106(2):312\u20138","DOI":"10.1016\/j.diabres.2014.08.017"},{"issue":"1","key":"4771_CR46","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3945\/ajcn.116.131110","volume":"105","author":"A Damms-Machado","year":"2017","unstructured":"Damms-Machado A, Louis S, Schnitzer A, Volynets V, Rings A, Basrai M, Bischoff SC (2017) Gut permeability is related to body weight, fatty liver disease, and insulin resistance in obese individuals undergoing weight reduction. Am J Clin Nutr 105(1):127\u2013135","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"4771_CR47","doi-asserted-by":"publisher","DOI":"10.4161\/tisb.27321","volume":"1","author":"T Vanuytsel","year":"2013","unstructured":"Vanuytsel T, Vermeire S, Cleynen I (2013) The role of haptoglobin and its related protein, zonulin, in inflammatory bowel disease. Tissue Barriers 1(5):e27321","journal-title":"Tissue Barriers"},{"key":"4771_CR48","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.bbamem.2008.10.028","volume":"1788","author":"JA Guttman","year":"2009","unstructured":"Guttman JA, Finlay BB (2009) Tight junctions as targets of infectious agents. Biochim Biophys Acta 1788:832\u2013841","journal-title":"Biochim Biophys Acta"},{"issue":"17","key":"4771_CR49","doi-asserted-by":"publisher","first-page":"3905","DOI":"10.3390\/jcm10173905","volume":"10","author":"E Szymanska","year":"2021","unstructured":"Szymanska E, Wierzbicka A, Dadalski M, Kierkus J (2021) Faecal zonulin as a noninvasive biomarker of intestinal permeability in pediatric patients with inflammatory bowel diseases-correlation with disease activity and faecal calprotectin. J Clin Med 10(17):3905","journal-title":"J Clin Med"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-022-04771-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-022-04771-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-022-04771-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T13:04:13Z","timestamp":1679058253000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-022-04771-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,13]]},"references-count":49,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["4771"],"URL":"https:\/\/doi.org\/10.1007\/s00431-022-04771-7","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,13]]},"assertion":[{"value":"22 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Review Board of the University of Naples \u201cFederico II\u201d approved the study protocol with the registration number 258\/20.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from the parents of all children, and from children themselves if older than 12\u00a0years.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}